1-(2-(2-Hydroxy Ethoxy)-Ethyl) Piperazine ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼ : ¿ëµµº°, Áö¿ªº°, ºÎ¹® ¿¹Ãø(2025-2030³â)
1-(2-(2-Hydroxy Ethoxy)-Ethyl) Piperazine Piperazine Market Size, Share & Trends Analysis Report By Application, By Region, And Segment Forecasts, 2025 - 2030
»óǰÄÚµå
:
1701621
¸®¼Ä¡»ç
:
Grand View Research, Inc.
¹ßÇàÀÏ
:
2025³â 03¿ù
ÆäÀÌÁö Á¤º¸
:
¿µ¹® 80 Pages
¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
½ÃÀå ±Ô¸ð¿Í µ¿Çâ :
¼¼°èÀÇ 1-(2-(2-Hydroxy Ethoxy)-Ethyl) Piperazine ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 5,550¸¸ ´Þ·¯¿¡ ´ÞÇß°í 2025³âºÎÅÍ 2030³â¿¡ °ÉÃÄ CAGR 3.5%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
1-(2-(2-Hydroxy Ethoxy)-Ethyl) PiperazineÀº ÁÖ·Î Ç×Á¤½Åº´Á¦ÀΠǪ¸¶¸£»ê ÄùƼ¾ÆÇÉÀÇ Á¦Á¶¿¡ »ç¿ëµÇ´Â ÈÇÐ Áß°£Ã¼ÀÔ´Ï´Ù. Á¤½ÅºÐ¿Áõ, ½Ö±Ø¼º Àå¾Ö, ¿ì¿ïÁõ µîÀÇ Á¤½ÅÁúȯÀÇ À¯º´·ü Áõ°¡¿Í Ç×Á¤½Åº´¾àÀÇ ¼¼°è ¼ö¿ä Áõ°¡°¡ 1-(2-(2-Hydroxy Ethoxy)-Ethyl) Piperazine ¼ö¿ä¸¦ Å©°Ô °ßÀÎÇϰí ÀÖ½À´Ï´Ù.
1-(2-(2-Hydroxy Ethoxy)-Ethyl) PiperazineÀº ÄùƼ¾ÆÇÉ ÇÕ¼ºÀÇ Áß¿äÇÑ Áß°£Ã¼À̱⠶§¹®¿¡ ÀÌ·¯ÇÑ ÀǾàǰ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â 1-(2-(2-Hydroxy Ethoxy)-Ethyl) Piperazine ½ÃÀå¿¡ Á÷Á¢ ¿µÇâÀ» ¹ÌĨ´Ï´Ù.
ÀϺΠºê·£µå Ç×Á¤½Åº´Á¦ÀÇ Æ¯Çã°¡ ²÷¾îÁø °ÍÀ¸·Î, Á¦³×¸¯ ÀǾàǰÀÇ »ý»êÀÌ ±ÞÁõÇϰí 1-(2-(2-Hydroxy Ethoxy)-Ethyl) Piperazine ¼ö¿ä¸¦ ´õ¿í ¹Ð¾î ¿Ã¸®°í ÀÖ½À´Ï´Ù. ÈÇÐÀû ÇÕ¼º ±â¼úÀÇ Áøº¸´Â Á¦¾à ȸ»ç¿¡°Ô 1-(2-(2-Hydroxy Ethoxy)-Ethyl) PiperazineÀ» ´õ¿í ¸Å·ÂÀûÀÎ ¼±ÅÃÀ¸·Î »ï°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ Á¦¾à ¾÷°è¿¡¼ ÁøÇàÁßÀÎ ¿¬±¸ °³¹ßÀº 1-(2-(2-Hydroxy Ethoxy)-Ethyl) PiperazineÀÇ »õ·Î¿î Ä¡·á ¿ëµµÀÇ ±âȸ¸¦ ³º°í ´Ù¾çÇÑ ¾àÁ¦ Á¦Á¦¿¡ÀÇ ¿ëµµ°¡ ÆÛÁú °¡´É¼ºÀÌ ÀÖ½À´Ï´Ù.
¸ñÂ÷
Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§
Á¦2Àå ÁÖ¿ä ¿ä¾à
Á¦3Àå ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§
- ¼¼°èÀÇ 1-(2-(2-Hydroxy Ethoxy)-Ethyl) Piperazine ½ÃÀå Àü¸Á
- ¹ë·ùüÀÎ ºÐ¼®
- ¿øÀç·á Àü¸Á
- Á¦Á¶/±â¼ú Àü¸Á
- ÆÇ¸Å ä³Î ºÐ¼®
- °¡°Ý µ¿Ç⠺м®
- °¡°Ý¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ¿äÀÎ
- ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©
- ½ÃÀå ¿ªÇÐ
- ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
- ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
- ½ÃÀå °úÁ¦ ºÐ¼®
- ½ÃÀå ±âȸ ºÐ¼®
- Porter's Five Forces ºÐ¼®
- °ø±Þ±â¾÷ÀÇ Çù»ó·Â
- ±¸¸ÅÀÚÀÇ Çù»ó·Â
- ´ëü À§Çù
- ½Å±Ô Âü°¡¾÷üÀÇ À§Çù
- °æÀï ±â¾÷°£ °æÀï °ü°è
- PESTLE ºÐ¼®
- Á¤Ä¡
- °æÁ¦
- »çȸ ȯ°æ
- 񃬣
- ȯ°æ
- ¹ý·ü
Á¦4Àå 1-(2-(2-Hydroxy Ethoxy)-Ethyl) Piperazine ½ÃÀå : ¿ëµµº° ÃßÁ¤ ¹× µ¿Ç⠺м®
- 1-(2-(2-Hydroxy Ethoxy)-Ethyl) Piperazine ½ÃÀå : ¿ëµµº° º¯µ¿ ºÐ¼®(2023³â, 2030³â)
- Á¦¾à
- ÈÀåǰ
- ³ó¾à
- ±âŸ
Á¦5Àå 1-(2-(2-Hydroxy Ethoxy)-Ethyl) Piperazine ½ÃÀå : Áö¿ªº° ÃßÁ¤ ¹× µ¿Ç⠺м®
- Áö¿ªº° ºÐ¼®(2023³â, 2030³â)
- ºÏ¹Ì
- ¿ëµµº°(2018-2030³â)
- ¹Ì±¹
- ij³ª´Ù
- ¸ß½ÃÄÚ
- À¯·´
- ¿ëµµº°(2018-2030³â)
- µ¶ÀÏ
- ¿µ±¹
- ÇÁ¶û½º
- ÀÌÅ»¸®¾Æ
- ½ºÆäÀÎ
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- ¿ëµµº°(2018-2030³â)
- Áß±¹
- Àεµ
- ÀϺ»
- Çѱ¹
- ¶óƾ¾Æ¸Þ¸®Ä«
- ¿ëµµº°(2018-2030³â)
- ºê¶óÁú
- ¾Æ¸£ÇîÆ¼³ª
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
- ¿ëµµº°(2018-2030³â)
- ³²¾ÆÇÁ¸®Ä«
- »ç¿ìµð¾Æ¶óºñ¾Æ
Á¦6Àå °æÀï ±¸µµ
- ÁÖ¿ä ½ÃÀå ÁøÃâ±â¾÷ÀÇ ÃÖ±Ù µ¿Çâ
- ±â¾÷ ºÐ·ù
- ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®(2024³â)
- ±â¾÷ÀÇ ½ÃÀå Æ÷Áö¼Å´× ºÐ¼®(2024³â)
- »ý»ê´É·Â(2024³â)
- Àü·« ¸ÅÇÎ
- ±â¾÷ ÇÁ·ÎÆÄÀÏ/¸ñ·Ï
- Valeshvar Biotech
- Tokyo Chemical Industry(India) Pvt. Ltd.
- Shanghai Ruifu Chemical Co., Ltd.
- Surya Life Sciences Ltd.
- Suzhou Jingye Medicine &Chemical Co., Ltd.
KTH
¿µ¹® ¸ñÂ÷
Market Size & Trends:
The global 1-(2-(2-Hydroxy Ethoxy)-Ethyl) Piperazine market size was estimated at USD 55.5 million in 2024 and is projected to grow at a CAGR of 3.5% from 2025 to 2030. 1-(2-(2-Hydroxy Ethoxy)-Ethyl) Piperazine (HEEP) is a chemical intermediate primarily used in the production of Quetiapine Fumarate, an antipsychotic medication. It is also being explored for potential use in other pharmaceutical formulations. The growing prevalence of psychiatric disorders such as schizophrenia, bipolar disorder, and depression, combined with the increasing demand for antipsychotic drugs globally, has significantly driven the demand for HEEP.
As HEEP is a crucial intermediate in the synthesis of Quetiapine, the rising demand for such medications directly impacts the market for HEEP. Furthermore, the expansion of pharmaceutical production capacity, particularly in the generic drug sector, also contributes to market growth.
With the expiration of patents for several branded antipsychotic drugs, there has been a surge in the production of generic alternatives, which further drives the demand for HEEP. Technological advancements in the chemical synthesis of HEEP, including more efficient and cost-effective manufacturing processes, have made it an even more attractive option for pharmaceutical companies. Additionally, ongoing research and development in the pharmaceutical industry are creating opportunities for new therapeutic applications of HEEP, potentially broadening its uses in various drug formulations.
Global 1-(2-(2-Hydroxy Ethoxy)-Ethyl) Piperazine Market Report Segmentation
This report forecasts revenue and volume growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global 1-(2-(2-Hydroxy Ethoxy)-Ethyl) Piperazine market report based on the application and region.
- Application Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2030)
- Pharmaceuticals
- Cosmetics
- Agrochemicals
- Others
- Regional Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2030)
- North America
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Asia Pacific
- China
- India
- Japan
- South Korea
- Latin America
- Middle East & Africa
- South Africa
- Saudi Arabia
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Market Definition
- 1.3. Information Procurement
- 1.3.1. Information Analysis
- 1.3.2. Market Formulation & Data Visualization
- 1.3.3. Data Validation & Publishing
- 1.4. Research Scope and Assumptions
- 1.4.1. List of Data Sources
Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segmental Outlook
- 2.3. Competitive Outlook
Chapter 3. Market Variables, Trends, and Scope
- 3.1. Global 1-(2-(2-Hydroxy Ethoxy)-Ethyl) Piperazine (HEEP) Market Outlook
- 3.2. Value Chain Analysis
- 3.2.1. Raw Material Outlook
- 3.2.2. Manufacturing/Technology Outlook
- 3.2.3. Sales Channel Analysis
- 3.3. Price Trend Analysis
- 3.3.1. Factors Influencing Prices
- 3.4. Regulatory Framework
- 3.5. Market Dynamics
- 3.5.1. Market Driver Analysis
- 3.5.2. Market Restraint Analysis
- 3.5.3. Market Challenges Analysis
- 3.5.4. Market Opportunity Analysis
- 3.6. Porter's Five Forces Analysis
- 3.6.1. Bargaining Power of Suppliers
- 3.6.2. Bargaining Power of Buyers
- 3.6.3. Threat of Substitution
- 3.6.4. Threat of New Entrants
- 3.6.5. Competitive Rivalry
- 3.7. PESTLE Analysis
- 3.7.1. Political
- 3.7.2. Economic
- 3.7.3. Social Landscape
- 3.7.4. Technology
- 3.7.5. Environmental
- 3.7.6. Legal
Chapter 4. 1-(2-(2-Hydroxy Ethoxy)-Ethyl) Piperazine (HEEP) Market: Application Estimates & Trend Analysis
- 4.1. 1-(2-(2-Hydroxy Ethoxy)-Ethyl) Piperazine (HEEP) Market: Application Movement Analysis, 2023 & 2030
- 4.2. Pharmaceuticals
- 4.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million) (Kilotons)
- 4.3. Cosmetics
- 4.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million) (Kilotons)
- 4.4. Agrochemicals
- 4.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million) (Kilotons)
- 4.5. Others
- 4.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million) (Kilotons)
Chapter 5. 1-(2-(2-Hydroxy Ethoxy)-Ethyl) Piperazine (HEEP) Market: Regional Estimates & Trend Analysis
- 5.1. Regional Analysis, 2023 & 2030
- 5.2. North America
- 5.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million) (Kilotons)
- 5.2.2. Market estimates and forecasts, by application, 2018 - 2030 (USD Million) (Kilotons)
- 5.2.3. U.S.
- 5.2.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million) (Kilotons)
- 5.2.3.2. Market estimates and forecasts, by application, 2018 - 2030 (USD Million) (Kilotons)
- 5.2.4. Canada
- 5.2.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million) (Kilotons)
- 5.2.4.2. Market estimates and forecasts, by application, 2018 - 2030 (USD Million) (Kilotons)
- 5.2.5. Mexico
- 5.2.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million) (Kilotons)
- 5.2.5.2. Market estimates and forecasts, by application, 2018 - 2030 (USD Million) (Kilotons)
- 5.3. Europe
- 5.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million) (Kilotons)
- 5.3.2. Market estimates and forecasts, by application, 2018 - 2030 (USD Million) (Kilotons)
- 5.3.3. Germany
- 5.3.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million) (Kilotons)
- 5.3.3.2. Market estimates and forecasts, by product, 2018 - 2030 (USD Million) (Kilotons)
- 5.3.3.3. Market estimates and forecasts, by application, 2018 - 2030 (USD Million) (Kilotons)
- 5.3.4. UK
- 5.3.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million) (Kilotons)
- 5.3.4.2. Market estimates and forecasts, by application, 2018 - 2030 (USD Million) (Kilotons)
- 5.3.5. France
- 5.3.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million) (Kilotons)
- 5.3.5.2. Market estimates and forecasts, by application, 2018 - 2030 (USD Million) (Kilotons)
- 5.3.6. Italy
- 5.3.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million) (Kilotons)
- 5.3.6.2. Market estimates and forecasts, by application, 2018 - 2030 (USD Million) (Kilotons)
- 5.3.7. Spain
- 5.3.7.1. Market estimates and forecasts, 2018 - 2030 (USD Million) (Kilotons)
- 5.3.7.2. Market estimates and forecasts, by application, 2018 - 2030 (USD Million) (Kilotons)
- 5.4. Asia Pacific
- 5.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million) (Kilotons)
- 5.4.2. Market estimates and forecasts, by application, 2018 - 2030 (USD Million) (Kilotons)
- 5.4.3. China
- 5.4.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million) (Kilotons)
- 5.4.3.2. Market estimates and forecasts, by application, 2018 - 2030 (USD Million) (Kilotons)
- 5.4.4. India
- 5.4.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million) (Kilotons)
- 5.4.4.2. Market estimates and forecasts, by application, 2018 - 2030 (USD Million) (Kilotons)
- 5.4.5. Japan
- 5.4.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million) (Kilotons)
- 5.4.5.2. Market estimates and forecasts, by application, 2018 - 2030 (USD Million) (Kilotons)
- 5.4.6. South Korea
- 5.4.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million) (Kilotons)
- 5.4.6.2. Market estimates and forecasts, by application, 2018 - 2030 (USD Million) (Kilotons)
- 5.5. Latin America
- 5.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million) (Kilotons)
- 5.5.2. Market estimates and forecasts, by application, 2018 - 2030 (USD Million) (Kilotons)
- 5.5.3. Brazil
- 5.5.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million) (Kilotons)
- 5.5.3.2. Market estimates and forecasts, by application, 2018 - 2030 (USD Million) (Kilotons)
- 5.5.4. Argentina
- 5.5.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million) (Kilotons)
- 5.5.4.2. Market estimates and forecasts, by application, 2018 - 2030 (USD Million) (Kilotons)
- 5.6. Middle East & Africa
- 5.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million) (Kilotons)
- 5.6.2. Market estimates and forecasts, by application, 2018 - 2030 (USD Million) (Kilotons)
- 5.6.3. South Africa
- 5.6.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million) (Kilotons)
- 5.6.3.2. Market estimates and forecasts, by application, 2018 - 2030 (USD Million) (Kilotons)
- 5.6.4. Saudi Arabia
- 5.6.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million) (Kilotons)
- 5.6.4.2. Market estimates and forecasts, by application, 2018 - 2030 (USD Million) (Kilotons)
Chapter 6. Competitive Landscape
- 6.1. Recent Developments by Key Market Participants
- 6.2. Company Categorization
- 6.3. Company Market Share Analysis, 2024
- 6.4. Company Market Positioning Analysis, 2024
- 6.5. Production Capacities, 2024
- 6.6. Strategy Mapping
- 6.7. Company Profiles/Listing
- 6.7.1. Valeshvar Biotech
- 6.7.1.1. Company Overview
- 6.7.1.2. Financial Performance
- 6.7.1.3. Product Benchmarking
- 6.7.2. Tokyo Chemical Industry (India) Pvt. Ltd.
- 6.7.2.1. Company Overview
- 6.7.2.2. Financial Performance
- 6.7.2.3. Product Benchmarking
- 6.7.3. Shanghai Ruifu Chemical Co., Ltd.
- 6.7.3.1. Company Overview
- 6.7.3.2. Financial Performance
- 6.7.3.3. Product Benchmarking
- 6.7.4. Surya Life Sciences Ltd.
- 6.7.4.1. Company Overview
- 6.7.4.2. Financial Performance
- 6.7.4.3. Product Benchmarking
- 6.7.5. Suzhou Jingye Medicine & Chemical Co., Ltd.
- 6.7.5.1. Company Overview
- 6.7.5.2. Financial Performance
- 6.7.5.3. Product Benchmarking
°ü·ÃÀÚ·á